SFG
HRMY icon

Steward Financial Group’s Harmony Biosciences HRMY Stock Holding History

Steward Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+15
New +$521 ﹤0.01% 1422
2022
Q3 		– Sell
-11
Closed – – 641
2022
Q2 		$0 Buy
+11
New +$495 ﹤0.01% 1147

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Steward Financial Group's HRMY Position: Q3 2023 in Review

Steward Financial Group opened a new position in Harmony Biosciences (HRMY) in Q3 2023: 15 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1422 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in HRMY as recently as Q2 2022.

Steward Financial Group first reported a position in HRMY in Q2 2022 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold HRMY as of Q3 2023.

  • Steward Financial Group held 15 shares of Harmony Biosciences worth $0 as of Q3 2023.
  • Harmony Biosciences was a new Steward Financial Group position in Q3 2023.
  • Harmony Biosciences made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1422 holding.
  • Steward Financial Group first reported a position in Harmony Biosciences in Q2 2022 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.